Stryker Corp (SYK) - Neurotechnology & Spine Revenue (DISCONTINUED) (I:SCSYKNSR)

More

Level Chart

Basic Info

Stryker Corp (SYK) - Neurotechnology & Spine Revenue is at a current level of 0.000, unchanged from 0.000 last quarter. This is a change of N/A from last quarter.
Report FinChat.io
Category Segments & KPIs
Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Sep 2023
Last Updated Nov 6 2023, 15:28 EST
Average Growth Rate -151.3%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 0.00
Change from 1 Year Ago N/A
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
Date Value
September 30, 2021 876.00M
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 820.00M
June 30, 2020 546.00M
March 31, 2020 744.00M
December 31, 2019 852.00M

News

Headline
Wire
Time (ET)
FinVolution Group to Report Third Quarter 2024 Financial Results on Monday, November 18, 2024
PR Newswire
11/05 05:00
Broadridge Launches New Digital Asset Information Platform to Help Financial Intermediaries Comply with Regulatory Guidelines
PR Newswire
10/31 07:30
DFIN Wins Nicsa's 2024 NOVA Award for Industry Innovation in Product Development
PR Newswire
10/30 06:30
Infosys Finacle Launches Data and AI Suite to Help Banks Accelerate their AI Journey
PR Newswire
10/30 06:11
FinVolution Unit Secures Funding Facility From PT Super Bank Indonesia
MT Newswires
10/29 10:06
FinVolution Subsidiary AdaKami Enters into Strategic Funding Agreement with PT Super Bank, Indonesia
PR Newswire
10/29 04:30
Dun & Bradstreet Introduces AI-Powered Chat Assistant for Business Data
MT Newswires
10/23 10:55
Fintech Sector Investment Remains Muted While Opportunity Persists in 2024; Silicon Valley Bank Releases Fourth Edition of Future of Fintech Report
PR Newswire
10/23 08:00
Climb Channel Solutions Launches NA Partnership with Software Management Platform Vendor, FinQuery
Globe Newswire
10/23 07:00
New Research from OneStream Finds Broader, More Strategic CFO Remit Crucial to Business Growth and Investor Attention, Overshadowing Even the CEO
PR Newswire
10/16 09:00

Basic Info

Stryker Corp (SYK) - Neurotechnology & Spine Revenue is at a current level of 0.000, unchanged from 0.000 last quarter. This is a change of N/A from last quarter.
Report FinChat.io
Category Segments & KPIs
Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Sep 2023
Last Updated Nov 6 2023, 15:28 EST
Average Growth Rate -151.3%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 0.00
Change from 1 Year Ago N/A
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
SYK Stryker Corp -0.07%

Related Indicators

Stryker Corp (SYK) - MedSurg & Neurotechnology Operating Income 924.00M USD
Stryker Corp (SYK) - MedSurg & Neurotechnology Revenue 3.224B USD
Stryker Corp (SYK) - MedSurg Operating Income (DISCONTINUED) 0.00 USD
Stryker Corp (SYK) - MedSurg Revenue (DISCONTINUED) 0.00 USD
Stryker Corp (SYK) - Neurotechnology & Spine Operating Income (DISCONTINUED) 0.00 USD
Stryker Corp (SYK) - Organic Net Sales Growth 11.50%
Stryker Corp (SYK) - Orthopaedics & Spine Operating Income 643.00M USD
Stryker Corp (SYK) - Orthopaedics & Spine Revenue 2.27B USD
Stryker Corp (SYK) - Orthopaedics Operating Income (DISCONTINUED) 0.00 USD
Stryker Corp (SYK) - Orthopaedics Revenue (DISCONTINUED) 0.00 USD